Results 101 to 110 of about 667,007 (283)

USP29‐regulated noncanonical stabilization of the hypoxia‐inducible factor‐α in aggressive prostate cancer

open access: yesMolecular Oncology, EarlyView.
We identify USP29 as the only DUB mirroring CA9 expression, a marker of hypoxia and HIF pathway activation associated with PCA aggressiveness. USP29 stabilizes HIF‐1α and HIF‐2α via a noncanonical mechanism that is independent of PHD/pVHL activity yet relies on proteasomal regulation, establishing USP29 as a previously unrecognized regulator of hypoxic
Amelie S Schober   +16 more
wiley   +1 more source

Primary antibodies used in western blotting.

open access: yes, 2019
Primary antibodies used in western blotting.
Małgorzata Chalimoniuk (4319206)   +6 more
core   +1 more source

Finding novel vulnerabilities of hypomorphic BRCA1 alleles

open access: yesMolecular Oncology, EarlyView.
Synthetic lethality screens performed to identify novel vulnerabilities often model complete gene loss, thereby overlooking patient‐derived hypomorphic mutations. In this study, we have performed genome‐wide CRISPR screens on BRCA1 hypomorphic mutations, showing BRCA1I26A behaves like wild‐type, while BRCA1R1699Q mimics deficiency. Furthermore, we have
Anne Schreuder   +10 more
wiley   +1 more source

Análisis de la expresión transgénica en plantas, mediante la técnica Western Blotting

open access: yesActa Biológica Colombiana, 2006
La transformación de plantas mediante la tecnología del DNA recombinante es un proceso cuyo resultado debe evaluarse a nivel molecular aplicando técnicas de análisis de la expresión transgénica.
Leidy Andrea Ávila Sánchez   +1 more
doaj  

Primary antibodies used for western blotting.

open access: yes, 2019
Primary antibodies used for western blotting.
Ying Zhao (16546)   +7 more
core   +1 more source

MITF maintains genome stability in nonmelanocyte lineages

open access: yesMolecular Oncology, EarlyView.
MITF is essential for melanocyte survival and acts as an oncogene in 10%–20% of melanomas. We show that MITF depletion causes genome instability in nonmelanocytic cells, leading to LATS2‐mediated P53 activation, cell cycle arrest, and apoptosis. This study highlights the role of MITF as a genome maintenance factor beyond the melanocyte lineage. Created
Drifa H. Gudmundsdottir   +13 more
wiley   +1 more source

List of antibodies used for Western blotting.

open access: yes, 2019
List of antibodies used for Western blotting.
Mohamed Ali Marey (3135117)   +11 more
core   +1 more source

Single cell–resolution western blotting [PDF]

open access: yes, 2016
This protocol describes how to perform western blotting on individual cells to measure cell-to-cell variation in protein expression levels and protein state.
Todd A Duncombe   +11 more
core   +1 more source

A novel quinazolinone insulin receptor inhibitor and its synergy with an EGFR inhibitor in glucose‐driven glioblastoma

open access: yesMolecular Oncology, EarlyView.
The novel styrylquinazolinone‐based molecule W1B effectively suppresses glioblastoma by inhibiting IGF1R and EGFR. In high‐glucose microenvironments driving tumor resistance, W1B acts synergistically with the EGFR inhibitor dacomitinib. This combination safely blocks compensatory survival signaling in zebrafish xenograft models. Showcasing promising in
Patryk Rurka   +9 more
wiley   +1 more source

Antibodies used for Western blotting and Immunohistochemistry.

open access: yes, 2016
Antibodies used for Western blotting and Immunohistochemistry.
Paula de Carvalho Papa (3203193)   +4 more
core   +1 more source

Home - About - Disclaimer - Privacy